Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Relation between plasma and brain lipids

Research output: Contribution to journalJournal articlepeer-review

  1. ANGPTL4: a new mode in the regulation of intravascular lipolysis

    Research output: Contribution to journalReviewpeer-review

  2. Polygenic risk scores: how much do they add?

    Research output: Contribution to journalReviewpeer-review

  3. Impact of metabolic dysfunction on cognition in humans

    Research output: Contribution to journalReviewpeer-review

  4. Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology

    Research output: Contribution to journalJournal articlepeer-review

  1. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Research output: Contribution to journalJournal articlepeer-review

  2. Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

PURPOSE OF REVIEW: This article evaluates recent experimental and human evidence regarding the involvement of lipids, lipoproteins, and apolipoproteins in neurodegenerative diseases, and reviews the current literature of the effects of cholesterol-lowering treatment on cognition.

RECENT FINDINGS: Plasma levels of traditional lipids and lipoproteins are not consistently associated with risk of dementia even though low plasma levels of apolipoprotein E, through unknown mechanisms, robustly predict future dementia. Experimental evidence suggests neuroprotective roles of several brain and cerebrospinal fluid apolipoproteins. Whether plasma levels of apolipoprotein E, or any other apolipoprotein with possible central nervous system and/or blood-brain barrier functions (apolipoproteins J, A-I, A-II, A-IV, D, C-I, and C-III) may become accessible biomarker components that improve risk prediction for dementia together with genetic risk variants and cardiovascular risk factors remains to be determined.

SUMMARY: Apolipoproteins with well established functions in peripheral lipid metabolism may play important roles for brain vascular health and Alzheimer's disease pathophysiology. Experimental work on lipids, lipoproteins, and apolipoproteins in the central nervous system together with robust prospective human studies will help to substantiate the drug target potential of these lipid components.

Original languageEnglish
JournalCurrent Opinion in Lipidology
Volume27
Issue number3
Pages (from-to)225-32
Number of pages8
ISSN0957-9672
DOIs
Publication statusPublished - Jun 2016

    Research areas

  • Journal Article

ID: 49458767